跳至主要内容
临床试验/NCT02901405
NCT02901405终止不适用

Negative Pressure Dressings Versus Non-negative Pressure Dressing for Wound Care Following Soft Tissue Sarcoma Excision

NHS Greater Glasgow and Clyde1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2016年10月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
17
试验地点
1
主要终点
Surgical Site Infection (proportion)

研究概览

简要总结

This randomised controlled trial aims to evaluate the difference in surgical site infection following excision of soft tissue sarcomas. The intervention is a negative wound pressure therapy dressing for 120 hours, the control is standard absorbent dressings

详细描述

Hypothesis

The application of a negative pressure wound therapy (NPWT) dressing will reduce rates of wound breakdown in patients with resection of soft tissue sarcomas which are primarily closed.

Patients will be randomised into either NPWT or standard absorbent dressings with primary outcome measure of surgical site infection according to the Health Protection Agency guidance. Secondary outcomes are; time to wound dryness, delayed discharge from hospital, adverse events, cost estimation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults undergoing primary soft tissue sarcoma excision which is primarily closed.

排除标准

  • •Unable to consent
  • •Post radiation sarcomas or sarcoma in presence of active infection
  • •Multiple metastatic disease
  • •Presence of Endoprosthesis

研究组 & 干预措施

Negative Pressure Wound Therapy

Experimental

120 hours of negative pressure wound therapy (ActiVAC, KCI) applied to a primarily closed ('acute') wound.

干预措施: Negative Pressure Wound Therapy (ActivVAC, KCI) (Device)

Standard dressings

Active Comparator

Absorbant dressings applied in a standard fashion, i.e. only changed as necessary

干预措施: Standard dressings (Device)

结局指标

主要结局

Surgical Site Infection (proportion)

时间窗: 30 days

As diagnosed by independent observer according to the Healthcare Protection Agency (UK) guidelines

次要结局

  • Delay to discharge form hospital (nominal scale)(30 days)
  • Adverse events (count)(30 days)
  • Cost analysis (comparative nominal scale in £)(30 days)
  • Time to wound dryness (nominal scale)(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验